JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹19 Cr | ₹16 Cr | ₹16 Cr | ₹21 Cr | ₹18 Cr |
What is the latest Total Current Liabilities ratio of JENBURKT PHARMACEUTICALS ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹19 Cr |
Mar2024 | ₹16 Cr |
Mar2023 | ₹16 Cr |
Mar2022 | ₹21 Cr |
Mar2021 | ₹18 Cr |
How is Total Current Liabilities of JENBURKT PHARMACEUTICALS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹19 Cr | 14.90 | |
Mar2024 | ₹16 Cr | 3.91 | |
Mar2023 | ₹16 Cr | -25.93 | |
Mar2022 | ₹21 Cr | 18.27 | |
Mar2021 | ₹18 Cr | - |
Compare Total Current Liabilities of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹581.3 Cr | 1.3% | 1.7% | 49.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | -2.1% | 1.7% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -1.5% | 1.5% | 46.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 2.5% | 11.2% | 15.3% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -1% | -1.7% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | -0.1% | -5% | -5.6% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | 1.3% |
1.7% |
49.2% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses